Open AccessDiagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Author(s) -
David N. Hanna,
Muhammad Owais Abdul Ghani,
Andrew Hermina,
Alexander Mina,
Christina E. Bailey,
Kamran Idrees,
Deepa Magge
Publication year - 2021
Publication title -
the american surgeon/american surgeon
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 93
eISSN - 1555-9823
pISSN - 0003-1348
DOI - 10.1177/00031348211048819
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , peritoneal carcinomatosis , perioperative , laparoscopy , cytoreductive surgery , surgery , complication , retrospective cohort study , colorectal cancer , cancer , ovarian cancer
Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) among patients with peritoneal carcinomatosis (PC) depend largely on the extent of peritoneal disease. Since PC is not reliably evaluated with cross-sectional imaging, tumor burden is often evaluated with diagnostic laparoscopy (DLS). The aims of this study are to evaluate the safety of DLS in patients with peritoneal disease and determine if DLS delays time to CRS-HIPEC.